HEADER CELL CYCLE 28-AUG-12 4B8M TITLE AURORA B KINASE IN COMPLEX WITH VX-680 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE B-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 78-361; COMPND 5 SYNONYM: AURORA/IPL1-RELATED KINASE 2-A, AIRK2-A, XAIRK2-A, COMPND 6 SERINE/THREONINE-PROTEIN KINASE 12-A, SERINE/THREONINE-PROTEIN COMPND 7 KINASE AURORA-B-A, XAURORA-B; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: INNER CENTROMERE PROTEIN A; COMPND 12 CHAIN: C, D; COMPND 13 FRAGMENT: RESIDUES 797-840; COMPND 14 SYNONYM: XL-INCENP, XINC, XINCENP, MITOTIC PHOSPHOPROTEIN 130; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 3 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 4 ORGANISM_TAXID: 8355; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 9 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 10 ORGANISM_TAXID: 8355; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CELL CYCLE, CANCER EXPDTA X-RAY DIFFRACTION AUTHOR F.SESSA,F.VILLA REVDAT 1 10-JUL-13 4B8M 0 JRNL AUTH F.SESSA,F.VILLA JRNL TITL STRUCTURAL AND BIOCHEMICAL ANALYSIS OF AN AURORA B KINASE JRNL TITL 2 MUTANT REVEALS A MULTISTEP ACTIVATION MECHANISM JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 116.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 97.88 REMARK 3 NUMBER OF REFLECTIONS : 55859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.19303 REMARK 3 R VALUE (WORKING SET) : 0.19078 REMARK 3 FREE R VALUE : 0.23561 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 2977 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.852 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.900 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3939 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.216 REMARK 3 BIN FREE R VALUE SET COUNT : 197 REMARK 3 BIN FREE R VALUE : 0.296 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5330 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.959 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.83 REMARK 3 B22 (A**2) : 1.82 REMARK 3 B33 (A**2) : -1.06 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -0.31 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.153 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.144 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.876 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5559 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7520 ; 1.161 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 655 ; 5.058 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 270 ;34.544 ;22.667 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1012 ;14.572 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 52 ;18.128 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 774 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4252 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2573 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3734 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 406 ; 0.113 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 133 ; 0.163 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 45 ; 0.164 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3308 ; 0.660 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5223 ; 1.110 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2546 ; 1.594 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2279 ; 2.624 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4B8M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-12. REMARK 100 THE PDBE ID CODE IS EBI-53907. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60080 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.85 REMARK 200 RESOLUTION RANGE LOW (A) : 30.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 6.6 REMARK 200 R MERGE (I) : 0.07 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.1 REMARK 200 R MERGE FOR SHELL (I) : 0.37 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.26 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.62950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 77 REMARK 465 THR A 78 REMARK 465 ALA A 79 REMARK 465 LEU A 80 REMARK 465 ALA A 81 REMARK 465 GLU A 82 REMARK 465 MET A 83 REMARK 465 PRO A 84 REMARK 465 LYS A 85 REMARK 465 ARG A 86 REMARK 465 THR A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 LYS A 361 REMARK 465 ASP A 362 REMARK 465 ALA B 77 REMARK 465 THR B 358 REMARK 465 GLN B 359 REMARK 465 SER B 360 REMARK 465 LYS B 361 REMARK 465 ASP B 362 REMARK 465 ASN C 838 REMARK 465 LYS C 839 REMARK 465 SER C 840 REMARK 465 PRO D 797 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 158 -176.36 -178.67 REMARK 500 ASP A 162 -157.80 -128.76 REMARK 500 ASP A 216 47.58 -151.75 REMARK 500 SER A 243 -42.97 -134.25 REMARK 500 GLN A 356 27.16 121.45 REMARK 500 ASN B 158 -175.05 -172.90 REMARK 500 ASP B 162 -169.91 -126.14 REMARK 500 ASP B 216 43.28 -150.33 REMARK 500 ASN D 838 -166.65 -109.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VX6 A1359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VX6 B1359 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BFX RELATED DB: PDB REMARK 900 MECHANISM OF AURORA-B ACTIVATION BY INCENP AND REMARK 900 INHIBITION BY HESPERADIN. REMARK 900 RELATED ID: 2BFY RELATED DB: PDB REMARK 900 COMPLEX OF AURORA-B WITH INCENP AND HESPERIDIN. REMARK 900 RELATED ID: 2VGO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REMARK 900 REVERSINE INHIBITOR REMARK 900 RELATED ID: 2VGP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REMARK 900 A AMINOTHIAZOLE INHIBITOR REMARK 900 RELATED ID: 2VRX RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439 REMARK 900 RELATED ID: 3ZTX RELATED DB: PDB REMARK 900 AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A REMARK 900 TAXOL-INDUCED CHECKPOINT SENSITIVITY SCREEN. REMARK 900 RELATED ID: 4B8L RELATED DB: PDB REMARK 900 AURORA B KINASE P353G MUTANT DBREF 4B8M A 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 4B8M B 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 4B8M C 797 840 UNP O13024 INCEA_XENLA 797 840 DBREF 4B8M D 797 840 UNP O13024 INCEA_XENLA 797 840 SEQADV 4B8M ALA A 77 UNP Q6DE08 EXPRESSION TAG SEQADV 4B8M ASP A 362 UNP Q6DE08 EXPRESSION TAG SEQADV 4B8M ALA B 77 UNP Q6DE08 EXPRESSION TAG SEQADV 4B8M ASP B 362 UNP Q6DE08 EXPRESSION TAG SEQRES 1 A 286 ALA THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR SEQRES 2 A 286 ILE ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY SEQRES 3 A 286 LYS PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN SEQRES 4 A 286 LYS PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN SEQRES 5 A 286 LEU GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU SEQRES 6 A 286 ILE GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU SEQRES 7 A 286 ARG MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR SEQRES 8 A 286 LEU MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS SEQRES 9 A 286 GLU LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER SEQRES 10 A 286 ALA THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR SEQRES 11 A 286 CYS HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO SEQRES 12 A 286 GLU ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE SEQRES 13 A 286 ALA ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG SEQRES 14 A 286 ARG ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO SEQRES 15 A 286 GLU MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP SEQRES 16 A 286 LEU TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL SEQRES 17 A 286 GLY MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR SEQRES 18 A 286 HIS ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO SEQRES 19 A 286 PHE LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU SEQRES 20 A 286 LEU ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY SEQRES 21 A 286 VAL MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG SEQRES 22 A 286 VAL LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS ASP SEQRES 1 B 286 ALA THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR SEQRES 2 B 286 ILE ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY SEQRES 3 B 286 LYS PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN SEQRES 4 B 286 LYS PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN SEQRES 5 B 286 LEU GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU SEQRES 6 B 286 ILE GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU SEQRES 7 B 286 ARG MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR SEQRES 8 B 286 LEU MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS SEQRES 9 B 286 GLU LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER SEQRES 10 B 286 ALA THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR SEQRES 11 B 286 CYS HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO SEQRES 12 B 286 GLU ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE SEQRES 13 B 286 ALA ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG SEQRES 14 B 286 ARG ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO SEQRES 15 B 286 GLU MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP SEQRES 16 B 286 LEU TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL SEQRES 17 B 286 GLY MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR SEQRES 18 B 286 HIS ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO SEQRES 19 B 286 PHE LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU SEQRES 20 B 286 LEU ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY SEQRES 21 B 286 VAL MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG SEQRES 22 B 286 VAL LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS ASP SEQRES 1 C 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 C 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 C 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 C 44 LEU PHE ASN LYS SER SEQRES 1 D 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 D 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 D 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 D 44 LEU PHE ASN LYS SER MODRES 4B8M TPO A 248 THR PHOSPHOTHREONINE MODRES 4B8M TPO B 248 THR PHOSPHOTHREONINE HET TPO A 248 11 HET TPO B 248 11 HET VX6 A1359 33 HET VX6 B1359 33 HETNAM TPO PHOSPHOTHREONINE HETNAM VX6 CYCLOPROPANECARBOXYLIC ACID {4-[4-(4-METHYL- HETNAM 2 VX6 PIPERAZIN-1-YL)-6-(5-METHYL-2H-PYRAZOL-3- HETNAM 3 VX6 YLAMINO)-PYRIMIDIN-2-YLSULFANYL]-PHENYL}- HETNAM 4 VX6 AMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 5 TPO 2(C4 H10 N O6 P) FORMUL 6 VX6 2(C23 H28 N8 O S) FORMUL 7 HOH *11(H2 O) HELIX 1 1 THR A 89 ASP A 91 5 3 HELIX 2 2 LYS A 126 GLY A 133 1 8 HELIX 3 3 VAL A 134 SER A 146 1 13 HELIX 4 4 LEU A 178 GLY A 186 1 9 HELIX 5 5 ASP A 189 ARG A 210 1 22 HELIX 6 6 LYS A 218 GLU A 220 5 3 HELIX 7 7 THR A 252 LEU A 256 5 5 HELIX 8 8 PRO A 257 GLU A 262 1 6 HELIX 9 9 LYS A 269 GLY A 285 1 17 HELIX 10 10 SER A 293 ASN A 303 1 11 HELIX 11 11 SER A 313 LEU A 324 1 12 HELIX 12 12 HIS A 327 ARG A 331 5 5 HELIX 13 13 PRO A 333 GLU A 339 1 7 HELIX 14 14 HIS A 340 SER A 347 1 8 HELIX 15 15 THR B 89 ASP B 91 5 3 HELIX 16 16 LYS B 126 GLY B 133 1 8 HELIX 17 17 VAL B 134 SER B 146 1 13 HELIX 18 18 LEU B 178 GLY B 186 1 9 HELIX 19 19 ASP B 189 ARG B 210 1 22 HELIX 20 20 LYS B 218 GLU B 220 5 3 HELIX 21 21 THR B 252 LEU B 256 5 5 HELIX 22 22 PRO B 257 GLU B 262 1 6 HELIX 23 23 LYS B 269 GLY B 285 1 17 HELIX 24 24 SER B 293 ASN B 303 1 11 HELIX 25 25 SER B 313 LEU B 324 1 12 HELIX 26 26 HIS B 327 ARG B 331 5 5 HELIX 27 27 PRO B 333 GLU B 339 1 7 HELIX 28 28 HIS B 340 SER B 347 1 8 HELIX 29 29 PRO C 799 ALA C 802 5 4 HELIX 30 30 SER C 803 LYS C 817 1 15 HELIX 31 31 ASP C 820 TYR C 825 1 6 HELIX 32 32 LYS C 832 PHE C 837 1 6 HELIX 33 33 PRO D 799 ALA D 802 5 4 HELIX 34 34 SER D 803 LYS D 817 1 15 HELIX 35 35 ASP D 820 TYR D 825 1 6 HELIX 36 36 LYS D 832 LEU D 836 5 5 SHEET 1 AA 5 PHE A 93 GLY A 100 0 SHEET 2 AA 5 VAL A 107 GLU A 112 -1 O VAL A 107 N LEU A 99 SHEET 3 AA 5 PHE A 117 PHE A 125 -1 O PHE A 117 N GLU A 112 SHEET 4 AA 5 ARG A 165 LEU A 170 -1 O ILE A 166 N LEU A 124 SHEET 5 AA 5 MET A 156 HIS A 161 -1 N TYR A 157 O MET A 169 SHEET 1 AB 3 GLY A 176 GLU A 177 0 SHEET 2 AB 3 LEU A 222 MET A 224 -1 N MET A 224 O GLY A 176 SHEET 3 AB 3 LEU A 230 ILE A 232 -1 O LYS A 231 N LEU A 223 SHEET 1 AC 2 VAL A 212 ILE A 213 0 SHEET 2 AC 2 VAL A 239 HIS A 240 -1 O VAL A 239 N ILE A 213 SHEET 1 BA 5 PHE B 93 PRO B 98 0 SHEET 2 BA 5 VAL B 107 GLU B 112 -1 O LEU B 109 N GLY B 96 SHEET 3 BA 5 PHE B 117 PHE B 125 -1 O PHE B 117 N GLU B 112 SHEET 4 BA 5 ARG B 165 LEU B 170 -1 O ILE B 166 N LEU B 124 SHEET 5 BA 5 MET B 156 HIS B 161 -1 N TYR B 157 O MET B 169 SHEET 1 BB 3 GLY B 176 GLU B 177 0 SHEET 2 BB 3 LEU B 222 MET B 224 -1 N MET B 224 O GLY B 176 SHEET 3 BB 3 LEU B 230 ILE B 232 -1 O LYS B 231 N LEU B 223 SHEET 1 BC 2 VAL B 212 ILE B 213 0 SHEET 2 BC 2 VAL B 239 HIS B 240 -1 O VAL B 239 N ILE B 213 LINK N TPO A 248 C ARG A 247 1555 1555 1.33 LINK C TPO A 248 N MET A 249 1555 1555 1.33 LINK C TPO B 248 N MET B 249 1555 1555 1.32 LINK N TPO B 248 C ARG B 247 1555 1555 1.33 CISPEP 1 TYR A 355 GLN A 356 0 3.84 SITE 1 AC1 11 LEU A 99 ALA A 120 LYS A 122 GLU A 171 SITE 2 AC1 11 PHE A 172 ALA A 173 PRO A 174 GLY A 176 SITE 3 AC1 11 GLU A 177 LEU A 223 ALA A 233 SITE 1 AC2 13 PHE B 104 LYS B 122 GLU B 171 PHE B 172 SITE 2 AC2 13 ALA B 173 PRO B 174 ARG B 175 GLY B 176 SITE 3 AC2 13 GLU B 177 LEU B 223 ALA B 233 ASP B 234 SITE 4 AC2 13 HOH B2005 CRYST1 45.787 67.259 116.755 90.00 96.58 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021840 0.000000 0.002519 0.00000 SCALE2 0.000000 0.014868 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008622 0.00000